![Young-Ho Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 46 038 $ al 28/02/2026
Young-Ho Kim is currently an Executive Board Member at Eutilex Co., Ltd. He received his undergraduate, graduate, and doctorate degrees from the University of Ulsan.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EUTILEX CO., LTD. 0,19 % | 30/09/2025 | 70.542 ( 0,19 % ) | 46 038 $ | 28/02/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EUTILEX.CO.,LTD | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
University of Ulsan
 University of Ulsan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eutilex Co., Ltd.
 Eutilex Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops anti-tumor T cell therapy and antibody therapeutics based on proprietary immunotherapy technology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
